ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,447Medicare Part D Prescriptions Filled, Including Refills

Rank: 260 out of 1121

$585K Total Retail Price of All Prescriptions

Rank: 306 out of 1121

487 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
15% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 487 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

12% of this provider’s 487 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 10,592 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
LISINOPRIL 547 520 1 4
AMLODIPINE BESYLATE 465 459 2 5
OMEPRAZOLE 456 404 3 6
LEVOTHYROXINE SODIUM 393 342 4 2
FUROSEMIDE 327 322 5 7
GABAPENTIN 294 257 6 13
SIMVASTATIN 287 262 7 1
HYDROCODONE-ACETAMINOPHEN 263 229 S3 8 3
PRAVASTATIN SODIUM 254 244 9 14
HYDROCHLOROTHIAZIDE 237 236 10 10
MELOXICAM 227 222 11 22
DOXAZOSIN MESYLATE 218 205 12 93
METOPROLOL SUCCINATE 209 209 13 23
POTASSIUM CHLORIDE 158 147 14 12
DIOVAN 157 140 15 45
LOSARTAN POTASSIUM 155 140 16 17
BENAZEPRIL HCL 155 144 16 41
ZOLPIDEM TARTRATE 153 138 18 19
METOPROLOL TARTRATE 141 131 19 9
MIRTAZAPINE 137 137 20 56
PAROXETINE HCL 133 133 21 58
SERTRALINE HCL 129 116 22 21
METFORMIN HCL ER 119 116 23 47
TRAZODONE HCL 117 115 24 40
METFORMIN HCL 115 90 25 8
NEXIUM 113 84 26 24
CYMBALTA 112 86 27 50
TRAMADOL HCL 112 94 27 25
LANTUS 109 109 29 52
TRIAMTERENE-HCTZ 108 90 30 38
TAMSULOSIN HCL 102 102 31 32
ATENOLOL 99 91 32 16
ISOSORBIDE MONONITRATE ER 93 93 33 62
RANITIDINE HCL 84 84 34 33
DONEPEZIL HCL 84 84 34 35
SYNTHROID 80 80 36 55
CITALOPRAM HBR 77 73 37 18
COLESTIPOL HCL 73 70 38 333
PREDNISONE 70 69 39 43
WARFARIN SODIUM 70 70 39 11
SUCRALFATE 69 68 41 193
LEVOXYL 68 65 42 151
DOXYCYCLINE HYCLATE 68 65 42 103
HYDRALAZINE HCL 65 65 44 66
CLOPIDOGREL 65 65 44 27
FLUTICASONE PROPIONATE 64 48 46 36
ADVAIR DISKUS 64 45 46 64
CIPROFLOXACIN HCL 63 60 48 57
TERAZOSIN HCL 62 62 49 130
KLOR-CON 10 61 61 50 69
GLIMEPIRIDE 60 60 51 34
AMITRIPTYLINE HCL 59 58 R 52 61
ATORVASTATIN CALCIUM 57 55 53 15
PANTOPRAZOLE SODIUM 53 53 54 29
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 22, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.